Login
Toggle navigation
Videos
Categories
Trending
Ben McMillan, founder and CIO of IDX Digital Assets, analyzes the future of crypto markets following recent downturns.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Ben McMillan, CIO of IDX Digital Assets,
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
brands can benefit most from headless commerce|Damir Becirovic,Partner,Index Ventures
00:00:00
Ellex Medical Lasers - a South Australian Health-tech success - Kara Cannon, CEO of Enzo Biochem, Inc.
00:10:00
"From the Gobi to Private Equity: An Interview with Dr. Weijian Shan"
00:10:00
Singular Health CEO Thomas Hanly Reflects on Successful First Quarter as ASX-Listed Company | Thomas Hanly, CEO , Singular Health Group Ltd.
00:00:00
Facial Paralysis: What to Expect - Samir Mardini, M.D. Facial Plastic Surgeon, Mayo clinic
00:10:00
Transitioning a Financial Practice: Nan Zimdars Shares Her Journey | C.J. Klaas, President, Klaas Financial.
00:10:00
Assessing the Sustainability of Contour Global's Dividend - Ted Wainman | Financial Analyst and Trainer | Talk Financials
00:10:00
Networking and Passion Prospecting: Building a Strong Client Base for Financial Advisors
00:10:00
Market Sentiment and Investment Opportunities in Commercial Real Estate and Private Credit | Jeff Aronson, Co-Founder, Centerbridge Partners.
00:10:00
Companies That Transform: Alicorp Discusses Its Winning Initiative | Alfredo Perez Gubbins, CEO, ALi Corp3041:TAI
00:10:00
Adapting to New Business Realities in South Africa: Challenges and Resilience Amid Logistics and Energy Constraints|DR NOMBASA TSENGWA,CHIEF EXECUTIVE OFFICER,Exxaro Resources Ltd.
00:10:00
Black Iron Inc: Leading Ukraine's High-Grade Iron Ore Project